Drugs & Pharmaceuticals M&A » By The Online Investor Staff, updated Fri., Apr. 26, 9:03 PM
Recent mergers and acquisitions in the Drugs & Pharmaceuticals M&A category.
Slide #34. McKesson Corporation — Celesio
Acquirer: |
McKesson Corporation (NYSE:MCK) |
Acquiree: |
Celesio |
Details: |
McKesson Corporation (NYSE:MCK), a leading North American healthcare services and information technology company, confirmed today that it has completed the previously announced agreement with Franz Haniel & Cie. GmbH to acquire their entire holding of Celesio shares. McKesson also confirmed it has completed the previously announced agreement with an affiliate of Elliott Management to acquire Celesio convertible bonds. McKesson now exceeds 75% ownership of Celesio shares on a fully diluted basis. |
McKesson is engaged in healthcare services. Co. operates its business in four reportable segments: U.S. Pharmaceutical, which distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; Prescription Technology Solutions, which provides prescription price transparency, benefit insight, dispensing support services, third-party logistics, and wholesale distribution support; Medical-Surgical Solutions, which provides medical-surgical supply distribution, logistics, and other services to healthcare providers; and International, which provides distribution and services to wholesale, institutional, and retail customers.
McKesson SEC Filing Email Alerts Service
Open the MCK Page at The Online Investor »
Company Name: |
McKesson Corp |
Website: |
www.mckesson.com |
Sector: |
Drugs & Pharmaceuticals |
Number of ETFs Holding MCK: |
115 |
Total Market Value Held by ETFs: |
$9.28B |
Total Market Capitalization: |
$70.36B |
% of Market Cap. Held by ETFs: |
13.19% |
|
Open the MCK Page at The Online Investor (in a new window) »
|
April 26, 2024 9:03 PM Eastern
Strong Buy (3.57 out of 4)
61st percentile
|
|